Insider Selling: Liquidia Technologies (NASDAQ:LQDA) Director Sells 154,337 Shares of Stock

Key Points

• Liquidia Technologies Director Paul Manning sold 154,337 shares for a total value of $4,312,175.78, reducing his ownership by 14.01%.
• The stock price of Liquidia Technologies increased by 3.3%, reaching $28.58, with a market cap of $2.46 billion.
• Liquidia Technologies reported a revenue increase of 141.5% year-over-year, with quarterly revenue of $8.84 million, despite missing EPS estimates.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) Director Paul B. Manning sold 154,337 shares of the firm's stock in a transaction on Thursday, August 28th. The shares were sold at an average price of $27.94, for a total transaction of $4,312,175.78. Following the completion of the transaction, the director directly owned 947,328 shares of the company's stock, valued at $26,468,344.32. This represents a 14.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Liquidia Technologies Stock Up 0.0%

Shares of NASDAQ:LQDA traded up $0.01 during midday trading on Friday, hitting $28.85. The stock had a trading volume of 1,409,821 shares, compared to its average volume of 3,019,348. Liquidia Technologies, Inc. has a 12 month low of $8.75 and a 12 month high of $29.94. The company has a quick ratio of 2.41, a current ratio of 2.49 and a debt-to-equity ratio of 9.84. The business's 50-day simple moving average is $20.43 and its 200-day simple moving average is $16.78. The company has a market cap of $2.48 billion, a P/E ratio of -16.97 and a beta of 0.22.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The firm had revenue of $8.84 million during the quarter, compared to the consensus estimate of $3.90 million. Liquidia Technologies's revenue was up 141.5% compared to the same quarter last year. On average, sell-side analysts forecast that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on LQDA shares. HC Wainwright lifted their price objective on shares of Liquidia Technologies from $29.00 to $35.00 and gave the stock a "buy" rating in a research report on Wednesday, May 28th. Raymond James Financial lifted their price objective on shares of Liquidia Technologies from $33.00 to $41.00 and gave the stock a "strong-buy" rating in a research report on Wednesday, August 13th. BTIG Research reaffirmed a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Wells Fargo & Company lifted their price objective on shares of Liquidia Technologies from $25.00 to $31.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 13th. Finally, Jefferies Financial Group started coverage on shares of Liquidia Technologies in a research report on Friday, August 15th. They set a "buy" rating and a $43.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Liquidia Technologies currently has a consensus rating of "Buy" and a consensus target price of $32.11.

Institutional Investors Weigh In On Liquidia Technologies

Institutional investors have recently modified their holdings of the business. NewEdge Advisors LLC bought a new stake in shares of Liquidia Technologies in the second quarter valued at about $25,000. Hurley Capital LLC acquired a new position in Liquidia Technologies in the first quarter valued at about $32,000. GAMMA Investing LLC raised its stake in Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after purchasing an additional 1,173 shares in the last quarter. Steward Partners Investment Advisory LLC raised its stake in Liquidia Technologies by 24.0% in the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company's stock valued at $77,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Quarry LP acquired a new position in Liquidia Technologies in the first quarter valued at about $79,000. Institutional investors own 64.54% of the company's stock.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).